Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor
暂无分享,去创建一个
[1] C. Carlberg,et al. Regulation of multiple insulin-like growth factor binding protein genes by 1α,25-dihydroxyvitamin D3 , 2005, Nucleic acids research.
[2] C. Carlberg,et al. Spatio-temporal activation of chromatin on the human CYP24 gene promoter in the presence of 1alpha,25-Dihydroxyvitamin D3. , 2005, Journal of molecular biology.
[3] C. Carlberg,et al. The Human Peroxisome Proliferator-activated Receptor δ Gene is a Primary Target of 1α,25-Dihydroxyvitamin D3 and its Nuclear Receptor , 2005 .
[4] C. Carlberg,et al. Regulation of the human cyclin C gene via multiple vitamin D3-responsive regions in its promoter , 2005, Nucleic acids research.
[5] J. Brooks,et al. Analysis of vitamin D‐regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays , 2004, The Prostate.
[6] R. Iggo,et al. Promoter-specific p53-dependent histone acetylation following DNA damage , 2004, Oncogene.
[7] P. N. MacDonald,et al. Vitamin D: more than a "bone-a-fide" hormone. , 2003, Molecular endocrinology.
[8] Xin Lu,et al. Live or let die: the cell's response to p53 , 2002, Nature Reviews Cancer.
[9] R. Iggo,et al. Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[10] C. Carlberg,et al. Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis. , 2001, Frontiers in bioscience : a journal and virtual library.
[11] J. Espinosa,et al. Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. , 2001, Molecular cell.
[12] P. Cohen,et al. Insulin-like growth factor binding protein-3 mediates 1 alpha,25-dihydroxyvitamin d(3) growth inhibition in the LNCaP prostate cancer cell line through p21/WAF1. , 2001, The Journal of urology.
[13] C. Carlberg,et al. All natural DR3-type vitamin D response elements show a similar functionality in vitro. , 2000, The Biochemical journal.
[14] A. Levine,et al. Surfing the p53 network , 2000, Nature.
[15] J. Chen,et al. The SRC family of nuclear receptor coactivators. , 2000, Gene.
[16] C. Carlberg,et al. Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4-type response elements. , 2000, Journal of molecular biology.
[17] J. Levine,et al. Surfing the p53 network , 2000, Nature.
[18] A. Aranda,et al. Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: role of the coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1). , 1999, Molecular endocrinology.
[19] Paul Tempst,et al. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex , 1999, Nature.
[20] R. Bouillon,et al. Action of 1,25(OH)2D3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cells , 1998, Molecular and Cellular Endocrinology.
[21] H. Erdjument-Bromage,et al. A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system. , 1998, Genes & development.
[22] C. Carlberg,et al. Gene regulation by vitamin D3. , 1998, Critical reviews in eukaryotic gene expression.
[23] C. Carlberg. The vitamin D(3) receptor in the context of the nuclear receptor superfamily : The central role of the retinoid X receptor. , 1996, Endocrine.
[24] Jerzy Jurka,et al. Censor - a Program for Identification and Elimination of Repetitive Elements From DNA Sequences , 1996, Comput. Chem..
[25] C. Carlberg,et al. Functional characterization of a 1,25-dihydroxyvitamin D3 receptor binding site found in the rat atrial natriuretic factor promoter. , 1996, Biochemical and biophysical research communications.
[26] L. Freedman,et al. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. , 1996, Genes & development.
[27] C. Carlberg,et al. The anti-proliferative effect of vitamin D3 analogues is not mediated by inhibition of the AP-1 pathway, but may be related to promoter selectivity. , 1995, Oncogene.
[28] Z. Su,et al. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. , 1994, Oncogene.
[29] K. Kinzler,et al. p53 tagged sites from human genomic DNA. , 1994, Human molecular genetics.
[30] Michael R. Green,et al. Nuclear protein CBP is a coactivator for the transcription factor CREB , 1994, Nature.
[31] D. Housman,et al. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents , 1993, Cell.
[32] C. Carlberg,et al. Two nuclear signalling pathways for vitamin D , 1993, Nature.
[33] K. Kinzler,et al. Definition of a consensus binding site for p53 , 1992, Nature Genetics.
[34] J. Grippo,et al. 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα , 1992, Nature.